Han Y - Search Results

1

Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.

Yuan C, Zhu X, Han Y, Song C, Liu C, Lu S, Zhang M, Yu F, Peng Z, Zhou C. Yuan C, et al. Among authors: han y. J Exp Clin Cancer Res. 2016 Jan 21;35:15. doi: 10.1186/s13046-016-0294-2. J Exp Clin Cancer Res. 2016. PMID: 26791264 Free PMC article.

2

Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry.

Han Y, Tu WW, Wen YG, Li DP, Qiu GQ, Tang HM, Peng ZH, Zhou CZ. Han Y, et al. Med Oncol. 2013;30(2):564. doi: 10.1007/s12032-013-0564-1. Epub 2013 Apr 17. Med Oncol. 2013. PMID: 23592225

3

Increased expression of TBX2 is a novel independent prognostic biomarker of a worse outcome in colorectal cancer patients after curative surgery and a potential therapeutic target.

Han Y, Tu WW, Wen YG, Yan DW, Qiu GQ, Peng ZH, Zhou CZ. Han Y, et al. Med Oncol. 2013 Dec;30(4):688. doi: 10.1007/s12032-013-0688-3. Epub 2013 Aug 20. Med Oncol. 2013. PMID: 23959449

4

Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.

Zhu X, Han Y, Yuan C, Tu W, Qiu G, Lu S, Lu H, Peng Z, Zhou C. Zhu X, et al. Among authors: han y. Oncol Rep. 2015 Jan;33(1):320-8. doi: 10.3892/or.2014.3559. Epub 2014 Oct 22. Oncol Rep. 2015. PMID: 25338725

5

Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.

Han Y, Lu S, Wen YG, Yu FD, Zhu XW, Qiu GQ, Tang HM, Peng ZH, Zhou CZ. Han Y, et al. Eur J Cell Biol. 2015 Dec;94(12):642-52. doi: 10.1016/j.ejcb.2015.08.004. Epub 2015 Nov 6. Eur J Cell Biol. 2015. PMID: 26552644

6

Overexpression of HOXB7 is associated with a poor prognosis in patients with gastric cancer.

Tu W, Zhu X, Han Y, Wen Y, Qiu G, Zhou C. Tu W, et al. Among authors: han y. Oncol Lett. 2015 Nov;10(5):2967-2973. doi: 10.3892/ol.2015.3630. Epub 2015 Aug 25. Oncol Lett. 2015. PMID: 26722273 Free PMC article.

7

SERPINA4 is a novel independent prognostic indicator and a potential therapeutic target for colorectal cancer.

Sun HM, Mi YS, Yu FD, Han Y, Liu XS, Lu S, Zhang Y, Zhao SL, Ye L, Liu TT, Yang DH, Sun XF, Qin XB, Zhou ZG, Tang HM, Peng ZH. Sun HM, et al. Among authors: han y. Am J Cancer Res. 2016 Aug 1;6(8):1636-49. eCollection 2016. Am J Cancer Res. 2016. PMID: 27648355 Free PMC article.

8

A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers.

Han Y, Lu S, Yu F, Liu X, Sun H, Wang J, Zhu X, Lu H, Yue H, Wang J, Lin J, Zhou C, Tang H, Peng Z. Han Y, et al. Sci Rep. 2016 Nov 15;6:37240. doi: 10.1038/srep37240. Sci Rep. 2016. PMID: 27845412 Free PMC article. Clinical Trial.

9

HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway.

Han Y, Song C, Wang J, Tang H, Peng Z, Lu S. Han Y, et al. Mol Carcinog. 2018 Jun;57(6):722-734. doi: 10.1002/mc.22793. Epub 2018 Feb 27. Mol Carcinog. 2018. PMID: 29436749

10

Pim1 supports human colorectal cancer growth during glucose deprivation by enhancing the Warburg effect.

Zhang M, Liu T, Sun H, Weng W, Zhang Q, Liu C, Han Y, Sheng W. Zhang M, et al. Among authors: han y. Cancer Sci. 2018 May;109(5):1468-1479. doi: 10.1111/cas.13562. Epub 2018 Apr 10. Cancer Sci. 2018. PMID: 29516572 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28,182 results

Search Page

Filters